about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.74
-0.02
(-2.63%)
272.4K
XNAS Volume
XNAS 17 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..